INTERNATIONAL PATENT: LYCIA THERAPEUTICS, INC. FILES APPLICATION FOR "LYSOSOMAL TARGETING BIFUNCTIONAL MOLECULES FOR DEGRADATION OF THYROID STIMULATING HORMONE RECEPTOR AUTOANTIBODIES"

GENEVA, Oct. 6 -- LYCIA THERAPEUTICS, INC. (400 East Jamie Court, Suite 200South San Francisco, California 94080) filed a patent application (PCT/US2025/021834) for "LYSOSOMAL TARGETING BIFUNCTIONAL MOLECULES FOR DEGRADATION OF THYROID STIMULATING HORMONE RECEPTOR AUTOANTIBODIES" on Mar 27, 2025. With publication no. WO/2025/207934, the details related to the patent application was published on Oct 02, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): LINDHOUT, Darrin Anthony (c/o Lycia Therapeutics, Inc.400 East Jamie Court, Suite 200South San Francisco, California 94080), SHURTLEFF, Matthew ...